PUBLISHER: The Business Research Company | PRODUCT CODE: 1957650
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957650
Phosphatidylcholine is an important phospholipid widely used across multiple industries for its emulsifying properties and role in cell repair. It is extensively applied in pharmaceuticals, cosmetics, and dietary supplements because of its benefits for liver health, fat metabolism, and skin care. Commercially, it is commonly sourced from soy or egg lecithin. Its functional versatility and biological activity make it a valuable component in rapidly growing health and wellness markets.
The main product types of phosphatidylcholine include liquid phosphatidylcholine and powder phosphatidylcholine. Liquid phosphatidylcholine is a naturally occurring phospholipid typically derived from soybeans or egg yolks and is used in medical and cosmetic applications to support cell membrane integrity and assist in fat metabolism. Phosphatidylcholine is obtained from various sources such as eggs, soybeans, sunflower, mustard, and others, and is available in different grades, including food grade, pharmaceutical grade, and cosmetic grade. It serves multiple functions, including acting as a moisturizing, solubilizing, and emulsifying agent. Based on application, it is used in pharmaceuticals, dietary supplements, cosmetics and personal care products, food and beverages, and other applications.
Tariffs have impacted the phosphatidylcholine market by increasing costs for imported raw materials such as soybeans, sunflower seeds, and egg-derived lecithin, as well as processing equipment. Pharmaceutical and cosmetic grade segments are most affected, particularly in regions like Asia-Pacific and Europe that rely on cross-border sourcing. These tariffs have contributed to higher production costs and pricing pressures. However, they have also encouraged local sourcing, alternative feedstock development, and investments in domestic extraction and processing capabilities.
The phosphatidylcholine market research report is one of a series of new reports from The Business Research Company that provides phosphatidylcholine market statistics, including phosphatidylcholine industry global market size, regional shares, competitors with a phosphatidylcholine market share, detailed phosphatidylcholine market segments, market trends and opportunities, and any further data you may need to thrive in the phosphatidylcholine industry. This phosphatidylcholine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phosphatidylcholine market size has grown strongly in recent years. It will grow from $1.47 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to traditional use of lecithin in food processing, growing awareness of lipid-based nutrition, expansion of cosmetic emulsifier usage, increasing pharmaceutical excipient demand, availability of soy and egg-based raw materials.
The phosphatidylcholine market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising nutraceutical and dietary supplement consumption, growth in personalized nutrition and wellness products, increasing demand for clean-label and sustainable ingredients, technological advancements in phospholipid extraction, expanding applications in drug delivery systems. Major trends in the forecast period include rising demand for liver health and metabolic supplements, increasing use in cosmetic and skin repair formulations, growing preference for plant-based and non-gmo sources, expansion of functional food and beverage applications, higher adoption of high-purity pharmaceutical grade ingredients.
The growing consumer demand for dietary supplements is anticipated to drive the growth of the phosphatidylcholine market in the coming years. Dietary supplements are products that contain vitamins, minerals, herbs, amino acids, or other ingredients intended to complement the diet and support overall health. The increase in consumer demand for dietary supplements is largely driven by individuals seeking convenient health solutions that align with wellness objectives, address nutritional deficiencies, and integrate easily into busy lifestyles without requiring significant dietary changes. Phosphatidylcholine plays an important role in dietary supplements by supporting cellular structure, assisting fat metabolism, and promoting liver health, making it a valuable ingredient for overall wellness enhancement. For instance, in October 2023, according to the Council for Responsible Nutrition, a US-based trade association, consumer confidence in the safety and quality of sports nutrition supplements increased to 66% in 2023 from 61% the previous year, while confidence in weight management supplements rose to 56% from 52% in 2022. Therefore, the rising consumer demand for dietary supplements is fueling the growth of the phosphatidylcholine market.
Major companies operating in the phosphatidylcholine market are concentrating on the development of advanced formulations that provide functional cognitive support, with the aim of improving brain health and memory while addressing the increasing demand for effective dietary supplements. Functional cognitive support refers to ingredients or products formulated to help maintain or enhance cognitive functions such as memory, focus, and mental clarity. For example, in August 2024, Kewpie Corporation, a Japan-based food manufacturing company, introduced Choline EX, a food-with-function-claims supplement derived from egg yolk choline, designed to support verbal memory and cognitive health in middle-aged and older adults. This launch represents the first commercial supplement in Japan to utilize egg yolk choline as its functional ingredient, responding to the growing need for cognitive health support within an aging population.
In July 2023, Croda International Plc, a UK-based chemicals company, acquired Solus Biotech Co., Ltd. for $263 million. Through this acquisition, Croda aims to reinforce its position as a global leader in sustainable and natural active ingredients by expanding its biotechnology capabilities, strengthening its portfolio of ceramides and phospholipids for beauty care and pharmaceutical uses, increasing its manufacturing and innovation footprint in North Asia, and accelerating growth in premium global markets. Solus Biotech Co., Ltd. is a South Korea-based company that develops and produces pharmaceutical and beauty ingredients, including phosphatidylcholine.
Major companies operating in the phosphatidylcholine market are Cargill Inc., Archer Daniels Midland (ADM), Bunge Limited, Kewpie Corporation, Croda International Plc, NOF Corporation, Nippon Fine Chemical, Cayman Chemical, Lipoid GmbH, VAV Life Sciences, Lucas Meyer Cosmetics, Creative Biolabs Inc., Sonic Biochem, Jena Bioscience GmbH, PHOSPHOLIPID GMBH, MITUSHI BIO PHARMA, Yangzhou Gami Biochem Co. Ltd., Lecico GmbH, Nutrasal Inc., Chemcopia Ingredients Private Limited.
North America was the largest region in the phosphatidylcholine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phosphatidylcholine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the phosphatidylcholine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The phosphatidylcholine market consists of sales of dietary supplements (capsules, softgels), liver health formulations, liposomal drug delivery systems, cosmetic creams and serums, intravenous (IV) lipid emulsions, functional foods and beverages, and brain health supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Phosphatidylcholine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses phosphatidylcholine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for phosphatidylcholine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phosphatidylcholine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.